Idex (IEX) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings of $2.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 0.98%. A quarter ago, it was expected that this maker of the Jaws of Life device and other engineered products would post earnings of $1.75 per share when it actually produced earnings of $1.88, delivering a surprise of 7.43% ...

文章核心观点 - IDEX Corporation (IEX)将于7月31日发布2024年第二季度业绩报告 [1] - 公司过去4个季度均超出市场预期,平均超出6.3% [2] - 预计第二季度收入将同比下降1.8%至8.308亿美元,调整后每股收益将同比下降6.4%至2.04美元 [3] 行业和公司分析 健康与科技技术(HST)分部 - 生命科学、分析仪器和半导体市场疲软,预计HST分部收入将同比下降5.4%至3.213亿美元 [4] 流体与计量技术(FMT)分部 - 工业市场疲软,非经常性项目和订单量下降,农业业务周期性下滑,预计FMT分部收入将同比下降1.5%至3.204亿美元 [5] 消防及多元化产品(Fire & Safety/Diversified Products)分部 - 消防和安全以及Band-It业务强劲,工业和市政市场表现良好,预计该分部收入将同比增长0.7%至1.861亿美元 [7] 整体经营情况 - 原材料成本上升和销售、管理费用增加,预计公司营业利润率将同比下降130个基点至22.3% [6] - 2023年12月收购STC Material Solutions有助于提升收入 [8]

文章核心观点 - IDEX公司业务表现良好,通过收购扩大产品组合,为未来增长奠定基础 [1][2][5][6] - IDEX公司积极回报股东,通过增加股息分配提升吸引力 [7] - 但IDEX公司部分业务板块表现疲软,以及费用上升给利润带来压力 [8][9] 公司业务表现 - IDEX公司的消防安全/多元化产品(FSDP)板块表现强劲,受益于工业和市政市场订单增加 [4] - 公司通过收购扩大产品组合,包括收购STC Material Solutions、Iridian Spectral和Muon Group等,增强了在材料科学、光学技术和精密技术方面的实力 [5][6] - 这些收购预计将在2024年为公司带来约1%的销售增长 [5][6] 股东回报 - IDEX公司在2024年前三个月的股息支付达4850万美元,同比增长6.6% [7] - 公司在2023年共分配股息1.907亿美元 [7] - 2024年5月公司宣布将季度股息提高7.8%至每股0.69美元 [7] 业务挑战 - IDEX公司的健康与科技(HST)和流体与计量技术(FMT)板块面临销量疲软,受到下游行业库存调整的影响 [8] - 农业业务持续低迷也拖累了FMT板块的表现 [8] - 销售、一般及管理费用不断上升,给利润带来压力 [9]

The board of directors of IDEX Biometrics ASA has resolved to issue 13,207,430 incentive subscription rights to 56 employees and individual contractors in the IDEX Biometrics group. The grant was made under the company's 2024 incentive subscription rights plan as resolved at the annual general meeting on 16 May 2024. The exercise price of the subscription rights is NOK 1.45 per share. The SRs vest by 1/3 per year over three years. The SRs expire on 16 May 2029. Following the company’s recent restructuring i ...

Nordroden/iStock via Getty Images I highlighted IDEX’s (NYSE:IEX) weak growth in Health & Science Technologies segment in my previous coverage published in February 2024. The company released its Q1 FY24 result on April 23rd and reaffirmed its full-year guidance. While I acknowledge that the Health & Science Technologies will continue to face challenges in FY24, IDEX’s order growth has already started to moderate. I reiterate 'Buy' rating with a fair price target of $220 per share. Order Moderation In Q ...

Oslo, Norway, 20 June 2024 – IDEX Biometrics has received a scaled repeat IDEX Access order from AuthenTrend, a global digital authentication leader. This order comes only a few months after the initial order, indicating customer demand for secure authentication, and marks the scaling of AuthenTrend’s biometric access cards. AuthenTrend, based out of Taiwan, focuses on digital document and identity verification. With a global reach and a strong presence in Asia, AuthenTrend provides a new generation of fing ...

IDEX Biometrics ASA held an extraordinary general meeting on 19 June 2024. 97.2 million shares or 31.6% of the share capital was represented at the meeting. Item 6 on the agenda, Board, was withdrawn because the nomination committee had not put forward any proposals. All other resolutions were passed as proposed by the board, with an update as regards dates in item 4 on the agenda, Subsequent offering. At agenda item 3, Private placement; Issue of Tranche 2 shares, the extraordinary general meeting resolv ...

IDEX Corporation (IEX) has been benefiting from strong performance of the Fire & Safety/Diversified Products (FSDP) segment, driven by increasing orders from industrial and municipal markets. Solid demand for products in the fire & safety and Band-It businesses is driving the FSDP segment’s revenues, of late. In the first quarter of 2024, the segment’s revenues increased 2% on a year-over-year basis. Driven by strength across its businesses, the company expects its overall organic revenues growth to be 0-2% ...

文章核心观点 - 公司将于2024年6月19日召开临时股东大会,采取在线会议形式,无实体参会选择 [1] - 临时股东大会是根据2024年5月15日完成的私募配股而召开的 [1] - 会议通知和参会表格将发送给股东,相关文件也可在公司网站获取 [2][3] - 公司是指纹生物识别技术领域的全球技术领导者,为支付、门禁和数字身份认证等领域提供认证解决方案 [4] 公司概况 - 公司名称为IDEX Biometrics ASA,在挪威证券交易所上市,股票代码为IDEX [4] - 公司致力于为全球带来便利、安全和无缝用户体验,基于专利和专有传感器技术、集成电路设计和软件 [4] - 公司作为行业推动者,与领先的卡片制造商和技术公司合作,将解决方案推向市场 [4] 联系方式 - 投资者关系负责人为Marianne Bøe [4] - 联系方式包括电子邮箱和电话 [4]

文章核心观点 - IDEX Biometrics ASA进行了一次私募配股,发行了3330万股新股[1] - 某些现有股东参与了股票借贷协议以配合此次配股[1] - 其中Robert Keith先生借出了17,940,213股[1] - 这些股票已经归还,Robert Keith及其关联方现持有34,710,479股或权益,占公司总股本和表决权的11.3%[2] 公司概况 - IDEX Biometrics ASA是一家指纹生物识别技术领导者,为支付、门禁和数字身份认证提供解决方案[3] - 公司的生物识别解决方案基于专利和专有的传感器技术、集成电路设计和软件[3] - 公司作为行业推动者与主要的卡片制造商和技术公司合作,将解决方案推向市场[3]